SNDL
SNDL
NASDAQ · Pharmaceuticals

Sndl Inc

$1.41
+0.05 (+3.68%)
As of May 9, 1:51 AM ET ·
Financial Highlights (FY 2026)
Revenue
977.58M
Net Income
-16,286,401
Gross Margin
27.3%
Profit Margin
-1.7%
Rev Growth
+9.9%
D/E Ratio
0.15
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 27.3% 27.3% 64.3% 64.3%
Operating Margin -0.8% -0.8% 39.2% 39.7%
Profit Margin -1.7% -1.6% 27.9% 35.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 977.58M 889.20M 59.12M 71.20M
Gross Profit 267.17M 243.02M 38.02M 45.80M
Operating Income -8,309,463 -6,802,361 23.17M 28.28M
Net Income -16,286,401 -13,332,509 16.50M 24.90M
Gross Margin 27.3% 27.3% 64.3% 64.3%
Operating Margin -0.8% -0.8% 39.2% 39.7%
Profit Margin -1.7% -1.6% 27.9% 35.0%
Rev Growth +9.9% +9.9% +13.8% -7.0%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 25.12M 25.12M 55.29M 58.47M
Total Equity 162.80M 162.80M 239.97M 225.54M
D/E Ratio 0.15 0.15 0.23 0.26
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 41.26M 35.66M 25.74M 34.11M
Free Cash Flow 14.78M 25.53M